differing natural courses,' and their inclusion could require intolerable variations in manage- ment.The hospice environment may seem more dis- tressing for patients with diseases other than cancer; moreover, if such patients were treated in hospices, patients with cancer might have greater difficulties with body image and in accepting the inconsistency of more active management being given for non-malignant diseases.5Hospices are deliberately not generally equipped to deliver such management so that overmedicalisation of terminal care is avoided.Presently hospices see only about half of patients with cancer, which leaves little scope for the needs of a wider population (estimated at 150% extra bed days required for patients with diseases other than cancer6).Hospice-style input for non-malignant diseases remains equally important but requires appro- priate provision in addition to traditional hospices.Adequate community services could also meet much of this need.Hospices offer quality rather than quantity and should not be seen as an easy and cheaper option for providing care for patients with terminal disease as if they were a homogeneous group.
No takes yet. Share an insight, caveat, or question.
Cook et al. (1995) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: